Darrois Villey Maillot Brochier advised Fareva within the context of the acquisition of a production site for ophthalmological, antifungal and antibiotic products from Laboratoires Merck Sharp & Dohme-Chibret (MSD)
Paris, 29 January 2021
Darrois Villey Maillot Brochier advised Fareva within the context of the acquisition of a production site located in Mirabel, Riom (63) from Laboratoires Merck Sharp & Dohme-Chibret (MSD). The facility of Mirabel is specialized in the production of ophthalmological, antifungal and antibiotic products.
Fareva is the world’s leading subcontractor in the industrial field for cosmetic, pharmaceutical, make-up, industrial and household products. The group achieved a turnover of 1.81 billion euros in 2019 and employs 12,000 employees in 41 production sites.
The Darrois Villey Maillot Brochier team included François Kopf, Jean-Baptiste de Martigny (partners), Christophe-Marc Juvanon and Caroline Vernet Leduc (associates) on corporate/M&A aspects and Henri Savoie (partner), Patrick Mèle (counsel) and Guillaume Griffart (associate) on public law and regulatory aspects.
Darrois Villey Maillot Brochier advises Bouygues in the context of its delisting offer followed by a squeeze-out on the shares of Colas
20 September 2023
Darrois Villey Maillot Brochier advised the ad hoc committee of Rothschild & Co in connection with the simplified tender offer launched by Concordia
18 September 2023